Skip to main content

Campylobacter Fetus Bacterin-Bovine

This page contains information on Campylobacter Fetus Bacterin-Bovine for veterinary use.
The information provided typically includes the following:
  • Campylobacter Fetus Bacterin-Bovine Indications
  • Warnings and cautions for Campylobacter Fetus Bacterin-Bovine
  • Direction and dosage information for Campylobacter Fetus Bacterin-Bovine

Campylobacter Fetus Bacterin-Bovine

This treatment applies to the following species:
Company: Colorado Serum

Campylobacter fetus Bacterin

U.S. Vet. Lic. No.: 188

Contents: A suspension of inactivated cultures of Campylobacter fetus subsp. fetus in a mineral oil adjuvant.

Contains thimerosal as a preservative.

Campylobacter Fetus Bacterin-Bovine Indications

For vaccinating healthy female cattle to aid in the control of bovine genital campylobacteriosis (vibriosis) caused by the subspecies named above.

Dosage and Administration

Inject 2 mL subcutaneously in top part of neck, 6" from ear.

Shake well to completely resuspend the organisms. Administer 30 to 60 days prior to exposure or addition to breeding herd. Revaccinate annually.

Precaution(s): Store in dark at 2° to 7°C, but remove from refrigeration and hold at room temperature 10-12 hours before use. Do not freeze.

Use entire contents when bottle is first opened.

Caution(s): Anaphylactoid reaction sometimes follows administration of products of this nature. If noted, administer adrenaline or equivalent.

Warning(s): Do not vaccinate within 60 days before slaughter.

For veterinary use only.

Presentation: 10 dose (20 mL) and 50 dose (100 mL) vials.

CPN: 11010070

4950 YORK STREET, P.O. BOX 16428, DENVER, CO, 80216-0428
Telephone:   303-295-7527
Order Desk:   800-525-2065
Fax:   303-295-1923
This service and data are provided "AS IS". DVMetrics and assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics and services and data. See the terms of use for further details.

Copyright © 2022 Animalytix LLC. Updated: 2021-11-29